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Complex nervous systems achieve proper connectivity during development and must maintain these connections throughout life. The
processes of axon and synaptic maintenance and axon degeneration after injury are jointly controlled by a number of proteins within
neurons, including ubiquitin ligases and mitogen activated protein kinases. However, our understanding of these molecular cascades is
incomplete. Here we describe the phenotype resulting from mutation of TMEM184b, a protein identified in a screen for axon degenera-
tion mediators. TMEM184b is highly expressed in the mouse nervous system and is found in recycling endosomes in neuronal cell bodies
and axons. Disruption of TMEM184b expression results in prolonged maintenance of peripheral axons following nerve injury, demon-
strating a role for TMEM184b in axon degeneration. In contrast to this protective phenotype in axons, uninjured mutant mice have
anatomical and functional impairments in the peripheral nervous system. Loss of TMEM184b causes swellings at neuromuscular junc-
tions that become more numerous with age, demonstrating that TMEM184b is critical for the maintenance of synaptic architecture. These
swellings contain abnormal multivesicular structures similar to those seen in patients with neurodegenerative disorders. Mutant animals
also show abnormal sensory terminal morphology. TMEM184b mutant animals are deficient on the inverted screen test, illustrating a role
for TMEM184b in sensory-motor function. Overall, we have identified an important function for TMEM184b in peripheral nerve terminal
structure, function, and the axon degeneration pathway.
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Introduction
Axons relay chemical and electrical information between cell
bodies and axon terminals (sensory endings and synapses), tra-
versing lengths up to a meter in the human body. The fidelity of
this connection is critical for sensory detection, muscle contrac-
tion, and neural network function. When an axon is damaged, it
initiates a molecular cascade leading to axon degeneration. Axon
damage occurs during traumatic or repetitive injury, following
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Significance Statement
Our work has identified both neuroprotective and neurodegenerative roles for a previously undescribed protein, TMEM184b.
TMEM184b mutation causes delayed axon degeneration following peripheral nerve injury, indicating that it participates in the
degeneration process. Simultaneously, TMEM184b mutation causes progressive structural abnormalities at neuromuscular syn-
apses and swellings within sensory terminals, and animals with this mutation display profound weakness. Thus, TMEM184b is
necessary for normal peripheral nerve terminal morphology and maintenance. Loss of TMEM184b results in accumulation of
autophagosomal structures in vivo, fitting with emerging studies that have linked autophagy disruption and neurological disease.
Our work recognizes TMEM184b as a new player in the maintenance of the nervous system.
The Journal of Neuroscience, April 27, 2016 • 36(17):4681– 4689 • 4681
(paclitaxel and vincristine), in diabetic neuropathy, and in many
inherited neurodegenerative conditions (Neukomm and Free-
man, 2014). Thus, understanding the events leading to axon
demise is critical for interfering with the progression of these
conditions.
Axon degeneration and death of cell bodies are separable pro-
cesses. For example, axon degeneration and synaptic terminal
loss precede cell body loss in Parkinson’s disease patients (Burke
and O’Malley, 2013) and in mouse models of CNS ischemia
(Zhang et al., 2010). Conversely, suppressing cell death does
not necessarily result in axon maintenance of diseased neurons
(Gould et al., 2006). In recent years, a number of proteins re-
quired for axon degeneration across species have been discov-
ered. These include DLK (wallenda in flies; Miller et al., 2009),
Phr1 (highwire; Xiong et al., 2012; Babetto et al., 2013), MORN4
(retinophilin; Bhattacharya et al., 2012), mitochondrial permea-
bility transition pore (Barrientos et al., 2011), and SARM1 (ect4;
Osterloh et al., 2012; Gerdts et al., 2013). While recent work has
delineated relationships among some of these players (Gerdts et
al., 2015; Yang et al., 2015), we do not fully understand how this
cascade is initiated and controlled, limiting our ability to interfere
in situations of pathological axon damage (Gerdts et al., 2016).
In an RNA interference-based screen in Drosophila for genes
that participate in axon degeneration following paclitaxel
(taxol) intoxication (Bhattacharya et al., 2012), we identified
TMEM184b, a uncharacterized 7-pass transmembrane protein.
In mice, we find that TMEM184b is highly expressed in the ner-
vous system, localizes to recycling endosomes within neuronal
cell bodies and their axons, and is required for axon degeneration
following sciatic nerve injury. Despite this protective effect of
TMEM184b loss in axons, TMEM184b mutants display progres-
sive structural abnormalities at the neuromuscular junction
(NMJ), swellings in intraepidermal sensory fibers, and functional
sensory-motor deficiencies. Our data demonstrate a critical role
for TMEM184b in regulating both axon degeneration and pe-
ripheral nervous system morphology and function.
Materials and Methods
Sequence similarity and hydrophobicity. Homologous proteins were iden-
tified using the Protein Basic Local Alignment Search Tool (National
Center for Biotechnology Information). Sequence identity and similarity
were calculated using online tools (http://imed.med.ucm.es/Tools/sias.
html). Hydrophobicity analysis was completed using the TMpred
software provided by ExPASy (http://www.ch.embnet.org/software/
TMPRED_form.html). All graphs and statistical analyses were done in
Igor Pro (WaveMetrics).
Mutant mice. Sperm from the Texas A&M Institute for Genomic Med-
icine allele Tmem184bGt (IST10294F4) were obtained and used to artifi-
cially inseminate C57BL/6 female mice. Mouse husbandry and surgeries
were performed in accordance with Washington University Institutional
Animal Care and Use Committee guidelines. In some instances, multiple
tissues were removed from the same animals to minimize the number of
animals used (foot pads, skeletal muscles, and brain tissue for quantita-
tive PCR). Both male and female animals were used in all experiments in
approximately equal numbers per genotype or comparison group. For all
graphs in all figures, ** indicates p  0.01, and * indicates p  0.05.
Genotyping. Genotyping was done using three primers, two flanking
the insertion site (left primer TCTGGGCAGAGATCTTGTGA, right
primer TTTTGCCAACACTCGTCACT) and a primer in the long termi-
nal repeat region of the gene-trap construct (Mut LTR2, AAATGGCGT
TACTTAAGCTAGCTTGC). Wild-type alleles produced a 461 bp prod-
uct, while mutant alleles produced a 266 bp product.
Xgal staining. Tissues were dissected from adult heterozygous mice
(1 year old), briefly fixed for 5–10 minutes in 5% paraformaldehyde,
and then treated with Xgal substrate (adult dorsal root ganglia for 40 min;
spinal cords for 1.25 h). Samples were then postfixed, immersed in 30%
sucrose overnight, and embedded in Optimal Cutting Temperature
(OCT) compound. Sections 10 m thick were cut, allowed to fix for 10
min, and then rinsed and mounted in 70% glycerol. Images were taken
on a Leica TCS SPE confocal microscope. Sections were additionally
stained with antibodies to Tuj1 (1:500; Biolegend) or ChAT (1:100;
Millipore).
Quantitative RT-PCR. Mice analyzed included four wild types (three
males and one female) and three mutants (two males and one female).
They were 1 year old. Mice were killed with carbon dioxide using
a SmartBox. Tissues were quickly removed and homogenized in Trizol
(Invitrogen). Total RNA was prepared, DNase-treated to remove
genomic contamination, and quantified (NanoDrop spectrophotome-
ter). cDNA was synthesized from 200 ng of total RNA (cDNA Synthesis
Kit, Quanta Biosciences), and 4% of this was used as a template for each
qPCR (Perfecta SYBR Green Fastmix, ROX, Quanta Biosciences). Reac-
tions were done in triplicate for each sample on an Applied Biosciences
7900HT quantitative PCR machine. Ct values were computed from am-
plification plots using a threshold in the linear range of amplification.
GAPDH was used to normalize samples and compute relative abun-
dance. Primers used were as follows: GAPDH, forward AGAGACGGC
CGCATCTTCTTG, reverse GCCGTTGAATTTGCCGTGAG; TMEM184b
forward CTCTCCTTCTGGCAAGGCAT, reverse GTCCAGTCTCTTGT
CAGCGT; TMEM184a, forward ATGGACTGCTCTGCTGCTAA, reverse
CAATGAACAGGAGGCGGATG; TMEM184c, forward CGCGGTTC
CGATATGCATTT, reverse TGACACGGGTATGGTTAGCA. All primers
were validated on positive control tissue (testes for TMEM184a; brain for
TMEM184b and TMEM184c).
Transfection, infection, and immunostaining. To create TMEM184b-
Myc virus, TMEM184b was amplified by PCR using a Myc-containing
primer on the 3 end, cloned into in an FCIV backbone (CMV promoter,
Ires-Venus) and packaged using VSV-G and 8.9 transfected into
HEK293T cells using Fugene (Promega). For sensory neuron expression
and colocalization with markers, the Ires-Venus cassette was removed to
allow for visualization of proteins using 488 nm excitation.
Primary embryonic dorsal root ganglion neurons were cultured from
CD1 embryos at day 13.5 as described previously (Miller et al., 2009) for
7– 8 d. Viruses were add on the first day in vitro. On the day of the
experiment, neurons were fixed for 20 min in 4% paraformaldehyde/
1PBS, rinsed in PBST, blocked with 5% goat serum, and incubated with
primary antibodies overnight. Antibodies used included rabbit anti-Myc
(1:100; Sigma-Aldrich C956), mouse anti-Myc (1:5000; clone 9B11, Cell
Signaling Technology), mouse anti-EEA1 (1:500; BD Transduction
Labs), rabbit anti-Rab11 (1:200; Cell Signaling Technology), mouse anti-
GM130 (1:1000; BD Transduction Labs), Ms anti-Tuj1 (see above). Sec-
ondary antibodies from Invitrogen (Alexa 488 anti-Ms or anti-Rb) or
Jackson Immunoresearch (Cy3 anti-Rb or Cy3 anti-Ms) were used at a
dilution of 1:500. Results were confirmed with four independent neuro-
nal preparations. Images were taken on a Leica TCS SPE confocal micro-
scope or a Nikon Eclipse E600 confocal microscope. TMEM184b
colocalization with Rab11 was quantified by examining single confocal
slices through neuronal soma (10 –20 cells per dissection analyzed). In
ImageJ, background fluorescence was subtracted from red and green
channels, and the Manders’ correlation coefficient was calculated using
the Coloc2 plugin with the Costes method for thresholding.
For muscle fiber analysis, tibialis anterior muscles (from two females
and one male per genotype) were removed and flash frozen, sectioned at
12 m thickness, and incubated with primary antibodies to LC3 (1:250;
Nanotools) and Lamp2 (1:400; Santa Cruz Biotechnology). Images were
brightened and contrast was enhanced in the red channel so as to see the
borders of myofibers in images.
Sciatic nerve injuries and analysis. For sciatic nerve studies, mice
(3 months old) were anesthetized with isoflurane and the right hindleg
of each was shaved and cleaned. Skin and muscle dorsal to the sciatic
nerve were opened with a small incision. A small chunk (1–2 mm) of
sciatic nerve was removed to ensure no regrowth across the injury site.
Following surgery, skin was stitched with three stitches, and animals were
transferred to recovery cages. Three or 5 d after surgery, animals were
killed with carbon dioxide and the distal section of the injured nerve was
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removed and fixed. For toluidine blue analysis, semithin sections (200
nm thick) were cut and stained with toluidine blue. The uninjured sciatic
nerve was used as a control and for normalization purposes.
Quantification of myelinated axon integrity was done by examining
four 100 images from nonoverlapping regions of toluidine blue-
stained sections of sciatic nerves from each mouse. Analysis was done
blinded to genotype. Axons were considered intact if they contained
undamaged cytoplasm and also contained clear mitochondria (small
pinpoints within cytoplasm). Empty or collapsed axons were not consid-
ered intact.
NMJ analysis. To examine NMJs, a fluorophore labeling all nerves
(thy1-YFP line 16; Feng et al., 2000) was bred into control and mutant
animals. Extensor hallucis longus (EHL) muscles were removed, fixed,
and incubated intact with fluorescently labeled -bungarotoxin (BTX;
Invitrogen) for 30 min. Muscles were then rinsed and mounted for con-
focal microscopy. Entire muscles were imaged at 10 and a stitched
image was created. Using these stitched images, and blinded to genotype,
all NMJs were scored for the presence or absence of swellings at nerve
terminals (75–125 NMJs scored per muscle per animal). Faint terminals
where morphology was not clear were not included in analysis. To ana-
lyze apposition, synapses of 6.5-month-old animals were manually iden-
tified on a multicolor image, and channels were then separated and
thresholded using ImageJ. Green (YFP) and red (BTX) areas were calcu-
lated for each synapse, and the red area was divided by the green area to
give a fractional apposition. Total acetylcholine receptor expression
per synapse was calculated by defining postsynaptic area using thresh-
olding, followed by summation of total pixel area multiplied by average
intensity.
Intra-epidermal nerve fiber analysis. Animals (two females and one
male per genotype) were humanely killed, and foot pads of mutant and
age-matched wild-type animals were removed, fixed, embedded in OCT
freezing media, and sectioned at 30 m thickness. Sections were stained
with rabbit anti-PGP9.5 (1:1000; Millipore) and DAPI to show nuclei
(contained within Vectashield mounting media; Vector Laboratories).
Quantification of total intraepidermal nerve fibers was done by adapting
a method of human skin biopsy analysis (Lauria et al., 2005). Sixty to 90
individual fibers were analyzed per animal. Fibers with swellings measur-
ing 3 fiber diameters were included in swelling counts.
Electron microscopy. Samples for electron microscopy were fixed in 4%
glutaraldehyde and processed according to standard protocols as de-
scribed previously (Bhattacharya et al., 2012). Imaging was done in the
Washington University Molecular Microbiology Electron Microscopy
Facility.
Functional and electrophysiological analysis. Electrophysiology was
performed on 6 –7-month-old mutant (five males, three females) and
wild-type (four males, four females) mice using a Nicolet Viking II elec-
tromyography system (Nicolet Biomedical). Throughout nerve conduc-
tion studies, mice received 2.5% isoflurane anesthesia. Motor nerve
velocity and amplitude of the left sciatic nerve were determined by in-
serting the recording electrode subcutaneously into the plantar surface of
the foot between the first and second digit and the reference electrode 2–3
mm lateral to it. For distal stimulation, the stimulating electrode was
inserted above the ankle; for proximal stimulation it was placed at the
sciatic notch. The nerve was stimulated with single square-wave pulses of
0.1 ms duration of increasing intensity until supramaximal responses
were generated. For sensory nerve recordings, the active recording elec-
trode was inserted 1 cm distal to the proximal tip of the tail and the
stimulating electrode 30 mm distally to the active recording electrode.
Supramaximal responses were generated using 0.1 ms square-wave
pulses and a train of 15 recordings was averaged. Motor and sensory
conduction velocities were calculated using the recording program. Slow
(2 Hz) and fast (50 Hz) repetitive nerve stimulation was performed by
stimulating at the sciatic notch and recording from the gastrocnemius
muscle. Each mouse received three trains of 10 stimuli at 2 and 50 Hz
with a pause of 2 min between each train of stimuli.
Tests with the inverted screen were performed on 6 –7-month-old
mice. The time mice held on to an inverted screen was recorded. The
experiment was stopped after 120 s or when mice fell off the screen,
whatever came first. Each mouse was tested three times and the average
time holding on to the screen was calculated.
Results
TMEM184b is a multipass transmembrane protein. Hydropho-
bicity analysis suggests that this protein contains seven trans-
membrane domains (Fig. 1A). The amino acid sequence of
TMEM184b has been highly conserved from flies to mice (57%
identical and 66% similar). To determine where TMEM184b is
expressed, we performed quantitative PCR on wild-type mouse
tissues. Our results show that TMEM184b is expressed in the
Figure 1. TMEM184b is expressed in central and peripheral neurons. A, Hydrophobicity plot of fly, mouse, and human TMEM184b showing seven transmembrane domains. B, Relative expression
of TMEM184b mRNA in wild-type tissues by quantitative PCR (n  3– 4 animals per tissue). S.C., Spinal cord; aDRG, adult dorsal root ganglia. Error bars are SEM. C, Quantitative PCR of TMEM184
family members from brain tissue of wild-type and mutant animals. Data are normalized to wild-type TMEM184b expression. n.s., Not significant. Student’s t test values for wild-type versus mutant:
TMEM184a, p  0.62; TMEM184b, p  2.0  10 	6; TMEM184c, p  0.26. D, E, Sections of adult dorsal root ganglion (D) and spinal cord (E) from a TMEM184b heterozygous mouse containing
one copy of the gene-trapped allele. Xgal stain is shown in blue. In D, an entire ganglion is shown to illustrate the extent of expression within sensory neurons. Red staining is -III tubulin (tuj1). In
E, red staining is ChAT, a marker of acetylcholine-producing motor neurons. Scale bars: D, 100 m; inset, 20 m; E, 10 m.
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nervous system, including both central (spinal cord, brain) and
peripheral (dorsal root ganglia) nervous tissues (Fig. 1B). In con-
trast, TMEM184b is expressed at minimal levels in muscle tissue.
This expression profile is consistent with RNA-seq (European
Molecular Biology Laboratory–European Bioinformatics Insti-
tute Expression Atlas) and in situ hybridization data (Allen Brain
Atlas) showing abundant brain, spinal cord, and dorsal root gan-
glion expression and scarce muscle expression of TMEM184b in
mouse. These studies show that TMEM184b is enriched in the
nervous system.
To undertake a functional analysis of TMEM184b, we ob-
tained mice in which the TMEM184b gene is disrupted by a gene-
trap cassette between the first and second exons (Texas A&M
Institute for Genomic Medicine allele Tmem184bGt (IST10294F4)).
Mice homozygous for the TMEM184b gene-trap allele are ho-
mozygous viable and fertile. Using adult brain tissue, we found
that in homozygous TMEM184b gene-trap (GT/GT) animals,
RNA expression of TMEM184b was severely reduced [5.5 

4.5% (SE) relative to wild-type; Fig. 1C, middle bars]. This rep-
resents an 20-fold reduction in TMEM184b RNA in GT/GT
mice. We will subsequently refer to these animals as TMEM184b
mutants. No change in the expression of other TMEM184 family
members was observed in mutant animals (Fig. 1C), demonstrat-
ing that they are not transcriptionally upregulated in response to
loss of TMEM184b.
To characterize the expression of TMEM184b in the nervous
system, we attempted to make a TMEM184b-specific antibody,
but our antibody was not able to recognize endogenous
TMEM184b protein (data not shown). Instead, we used the
-galactosidase expression derived from the gene-trap cassette to
visualize the cellular expression pattern of TMEM184b. In dorsal
root ganglia, TMEM184b is expressed in virtually all sensory neu-
ron cell bodies (Fig. 1D). In the ventral spinal cord, TMEM184b
expression is found in motor neurons expressing ChAT (Fig. 1E).
In summary, our data demonstrate expression of TMEM184b in
both motor and sensory neurons.
To study the intracellular localization of TMEM184b, we
generated a Myc-tagged version of the protein and introduced
this into neurons with a lentivirus. In primary cultures of dorsal
root ganglion neurons, TMEM184b is found in a vesicular pat-
tern. We see extensive colocalization of TMEM184b and Rab11,
a marker of recycling endosomes, in the soma (Fig. 2A).
TMEM184b protein is trafficked into axons, where it continues
to occupy Rab11-positive compartments (Fig. 2B,C). Therefore,
TMEM184b is found in recycling endosomes within distal axons,
where it could function in axon degeneration. In contrast to the
clear colocalization with Rab11, we find very little TMEM184b in
early endosomes (labeled by EEA1; Fig. 2D; Mu et al., 1995).
TMEM184b is found in areas adjacent to the Golgi apparatus
(labeled by GM130; Fig. 2E; Nakamura et al., 1995), but does not
colocalize with this compartment. The presence of TMEM184b
in recycling endosomes but not in Golgi or early endosomes sug-
gests that its localization is not an artifact of TMEM184b overex-
pression. Additionally, because recycling endosomes carry cargo
between the plasma membrane and internal compartments (van
Ijzendoorn, 2006), it suggests that TMEM184b protein is present
on the plasma membrane of neurons.
To ascertain whether TMEM184b is required for axon degen-
eration in mammals, we transected the sciatic nerves of mutant
and wild-type mice and examined axon integrity using toluidine
blue staining of distal nerve cross sections. Transected axons in
TMEM184b mutant animals show remarkable preservation 3 d
Figure 2. TMEM184b localizes to recycling endosomes within neuronal axons and soma. In all panels, TMEM184b-Myc has been virally expressed and identified with antibody to Myc (red). A, Cell
bodies of embryonic dorsal root ganglia neurons expressing TMEM184b-Myc. Box in the upper portion of the merged image shows region from which inset (bottom right corner of each image) is
taken. Yellow in the merged image indicates colocalization of Rab11 (green), a marker of recycling endosomes, and TMEM184b-Myc (red); 90 
 7% (SD) of TMEM184b-Myc signal overlaps with
Rab11 signal; 92 
 5% (SD) of Rab11 signal overlaps with TMEM184b-Myc signal (Manders’ correlation coefficient calculation, n  53). Arrows within insets show clusters of recycling endosomes
that contain TMEM184b. B, Axons of embryonic DRG neurons (7 d in vitro) stained for Tuj1 (green) and Myc (red). C, Co-occurrence of TMEM184b (red) and Rab11 (green) within axons. D, E, Double
immunostaining of TMEM184b-Myc (red) with (D) early endosomes (EEA1, green) or with (E) Golgi (GM130, green). Little to no overlap is seen for either compartment. Representative images from
four independent experiments are shown. Scale bars: A, D, E, 5 m; C, 10 m.
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following nerve injury, with 6 times the number of intact my-
elinated axons remaining at this time point when compared with
wild-type controls (Fig. 3A–C). This protection is not prolonged,
as mutant axons are lost by 5 d postinjury (Fig. 3B). These data
show that TMEM184b loss affords a short but significant delay in
axon degeneration following a severe nerve injury. Remak bun-
dles containing small-diameter C-fiber nociceptive axons did not
appear preserved in TMEM184b mutant animals following nerve
injury (Fig. 3D), suggesting that these unmyelinated fibers may
be more difficult to protect than myelinated ones. Electron mi-
croscopic analysis of mutant and wild-type axons revealed nor-
mal morphology of uninjured mutant axons (Fig. 3C,D). Thus,
TMEM184b promotes the degeneration of myelinated peripheral
axons in vivo.
To further characterize the nervous system phenotype of the
TMEM184b mutant mouse, we examined NMJs formed at the
EHL muscle. We noticed dramatic morphological changes in
the NMJs of mutant animals (Fig. 4A–D). In mutant animals,
large dystrophic swellings are present in presynaptic terminals.
These swellings are also found in synapses onto the tibialis ante-
rior and diaphragm muscles (data not shown), suggesting a wide-
spread problem with NMJ architecture. The frequency of these
swellings increases with age in mutant animals (Fig. 4G), a find-
ing suggesting that TMEM184b loss causes progressive neurode-
generative disease in these animals. In areas of presynaptic
swelling, postsynaptic receptor expression is virtually absent (Fig.
4C,D). Overall, we find that apposition of presynaptic terminals
declines dramatically in TMEM184b mutant animals, with 50%
of mutant synapses having less than half of their presynaptic area
opposed by acetylcholine receptors (Fig. 4H). We did not observe
an overall decrease in the amounts of receptor per synapse (mu-
tants had slightly increased expression, 1.6-fold of wild-type, n 
200 synapses; data not shown), arguing that terminal swellings
may have asymmetrically expanded the presynaptic side. Thus,
TMEM184b is required for proper NMJ morphology, and its
disruption results in defects in acetylcholine receptor apposition.
Given the high expression of TMEM184b in sensory as well as
motor neurons, we tested whether abnormalities occur in sensory
terminals of mutant animals. Foot pad intraepidermal nerve fiber
morphology was examined by staining for PGP9.5 (for review,
see Mellgren et al., 2013). We found dystrophic sensory fibers in
the epidermis of TMEM184b mutant animals, a phenotype strik-
ingly similar to that in motor terminals (Fig. 4E,F). Mutant an-
imals had significantly more swollen fibers than wild-type
controls [13.2 
 4.4% (SD) in mutant; 0.8 
 0.7% (SD) in wild
type; Student’s t test p  0.008]. This experiment shows that
TMEM184b is required for proper sensory terminal morphology.
When we examined TMEM184b mutant NMJs by electron mi-
croscopy, we found examples of swollen presynaptic terminals with
membranous aggregates (Fig. 5A–D). In the muscle, we found ag-
Figure 3. TMEM184b participates in the axon degeneration cascade. A, Toluidine blue-stained sections through sciatic nerves (SN) of spared and injured (distal) sciatic nerves in wild-type and
mutant animals. B, Quantification of the percentage of intact myelinated axons (showing cytoplasm and mitochondria) on the injured versus spared side at 3 and 5 d following sciatic nerve cut. N 
4 animals per genotype and treatment. **p  0.0004 (two-tailed t test). C, Electron micrographs of representative myelinated axons in the sciatic nerves of wild-type and mutant animals.
D, Representative sensory (Remak) axon bundles in each genotype and treatment. Scale bars: A, 20 m; C, 1 m; D, 500 nm.
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gregates of vesicles, some of which are clearly surrounded by a dou-
ble membrane characteristic of autophagosomes (Fig. 5E,F).
Furthermore, mutant muscle shows occasional myofibers with ab-
normal accumulations of autophagosomes and/or lysosomes in
their center (Fig. 5G,H). In summary, the abnormalities observed by
both light and electron microscopy in TMEM184b mutant mice sug-
gest impairments in autophagy.
To determine whether the structural abnormalities cause def-
icits in motor unit function in TMEM814b mutant mice, we
tested functional and electrophysiological parameters of motor
Figure 4. TMEM184b loss causes morphological defects at motor and sensory terminals. A, B, NMJs at the EHL muscle in heterozygous (A) or mutant (B) 8 –10-week-old mice. All nerves are green
(YFP); acetylcholine receptors in muscle are red (labeled with BTX). Arrows point to synaptic swellings at mutant synapses; yellow asterisk indicates a morphologically normal synapse. C, D,
TMEM184b mutant NMJs showing individual nerves (YFP, green) and acetylcholine receptors (BTX, red) in 6.5-month-old mice. Dashed lines in D indicate locations of presynaptic swellings where
little receptor apposition is found. E, F, Intraepidermal nerve fibers of wild-type and mutant animals, stained with PGP9.5 (red) and DAPI (blue). Dashed line shows the border between dermis (left)
and epidermis (right). Mutants show abnormal swellings within epidermal fibers (arrows). G, Quantification of synaptic swellings in control (filled boxes) and mutant (open boxes) animals over time.
p  2.5  10 	4 at 18 d; 1.6  10 	4 at 8 –10 weeks; 2.1  10 	5 at 6.5 months. N  3– 4 animals per genotype (**p  0.01). H, Quantification of the percentage of presynaptic terminal area
opposed by acetylcholine receptors (BTX). Black bars, Wild type; gray bars, mutant. Graph shows the percentage of analyzed synapses (n  40 – 60 synapses per mouse, 3 mice per genotype) that
have the indicated levels of apposition. P values calculated using one-way ANOVA ( p  0.025, 0.16, and 0.0033 for lowest, middle, and highest levels of apposition, respectively). Scale bars: (in A)
A, B, 20 m; (in C) C, D, 10 m; (in E) E, F, 20 m.
Figure 5. Electron and light microscopy reveal abnormal autophagosomal structures in TMEM184b mutant mice. A–F, Electron micrographs of TMEM184b mutant and control EHL muscles. A, B,
NMJs on the EHL in wild-type (A) or mutant (B) animals. Mutant synaptic terminals are abnormally shaped (protrusion in upper right corner) and contain membranous inclusions (arrows). C, D,
Enlargements of regions in B (mutant) shown by the white arrows. E, F, Examples of abnormal vesicular structures found near the muscle fiber surface in TMEM184b mutant mice. The inset in E shows
a double membrane surrounding this structure (arrow). G, H, Sections of skeletal muscle (tibialis anterior) stained with the autophagosomal marker LC3 (G) or the lysosomal marker Lamp2 (H ). In
mutant animals, occasional accumulations of LC3 or Lamp2-positive structures are found within muscle fibers. Dotted lines show borders of a single myofiber. Scale bars: A, B, 1 m; C, D, 500 nm;
E, F, 250 nm; inset in E, 100 nm.
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and sensory function. Mutant mice were not able to hold on to an
inverted screen, suggesting a deficit in sensory-motor function
(Fig. 6A). Action potential amplitudes (both sensory and com-
pound motor) and conduction velocities in both sensory and
motor nerves were indistinguishable between mutant and wild-
type animals (Fig. 6B–E), indicating that there is no motor or
sensory neuropathy. Therefore, while functional deficits exist in
TMEM184b mutant animals, they cannot be ascribed to conduc-
tion failure in nerves. To ask whether mice had a synaptic trans-
mission defect, we performed repetitive nerve stimulation (2 and
50 Hz) but saw no decrement in the amplitude or area of the
compound motor action potential in mutant animals, suggesting
the absence of a severe postsynaptic defect at the NMJ (data not
shown). However, we cannot rule out a more subtle defect in
synaptic transmission. In summary, TMEM184b mutant mice
have a sensory-motor functional defect that is consistent with
structural abnormalities found at their sensory and motor
terminals.
Discussion
We have described an important role for TMEM184b in the ner-
vous system in both nerve terminal maintenance and responses
to nerve injury. This represents the first description of a function
for mammalian TMEM184b in vivo.
The mammalian TMEM184 family contains three members,
TMEM184a, TMEM184b, and TMEM184c. TMEM184a [also
called TMEM34 (human) and lazarus1 (Arabidopsis)] and
TMEM184c (also called Sdmg1, or Osta-1 in Caenorhabditis el-
egans) share a domain structure with TMEM184b that is similar
to organic solute transporters. Roles ascribed to TMEM184a and
TMEM184c include control of cell migration and tumorigenesis
(Akaishi et al., 2007; Fukumoto et al., 2015), cilia architecture
(Olivier-Mason et al., 2013), and spermatogenesis (Best and Ad-
ams, 2009), although the molecular mechanisms are unknown.
Additionally, P-element insertions near Drosophila CG12004
cause defects in innate immunity (Jin et al., 2008) and in synaptic
target selection (Kurusu et al., 2008). However, there are no data
as to whether these insertions disrupt CG12004 expression or
that these phenotypes can be rescued by restoration of CG12004
protein.
We find that TMEM184b localizes to recycling endosomes in
mammalian cell bodies and axons (Fig. 2). Furthermore, our light
and electron microscopy analyses reveal abnormal accumula-
tions of autophagosomal structures, suggesting possible defects
with autophagic clearance of cellular debris (Fig. 5). These two
compartments are functionally linked; Rab11-positive recycling
endosomes contain the autophagy proteins ULK1 and Atg9, and
they contribute membranes to nascent autophagosomes (Lon-
gatti et al., 2012). Thus, one possible explanation for the defects
seen in TMEM184b mutant mice is a disruption in autophago-
somal structure or clearance, leading to the buildup of recycled
cargo in nerve terminals and at synapses.
Together, our data implicate TMEM184b in the regulation of
autophagy. Disorders involving autophagosomes can cause both
nerve and muscle disease. In neurons, autophagy is a constitutive
process (Maday et al., 2012). It is thought to function in the degra-
dation of proteins that, if accumulated, cause neurodegenerative dis-
eases like Huntington’s disease (Ravikumar et al., 2002; for review,
see Wong and Holzbaur, 2015). Correspondingly, defective au-
tophagy is a causative event in some familial forms of amyotrophic
lateral sclerosis (ALS; Fecto et al., 2011), and some loci linked to ALS
encode proteins regulating autophagosomes (Alegre-Abarrategui et
al., 2009; Ju et al., 2009; Hadano et al., 2010).
A number of mouse models of neurodegenerative disease show
similar phenotypes to that of TMEM184b. For example, both the
light and electron microscopic phenotypes in TMEM184b mutant
muscle bear significant similarity to rimmed vacuoles and inclusions
caused by dominant mutations in an autophagy regulator, valosin-
containing protein (VCP; Ju et al., 2009). VCP mutations can cause
not only ALS but also frontotemporal dementia and inclusion body
myopathy, illustrating how the dysfunction of protein degradative
Figure 6. TMEM184 loss causes sensory-motor impairment. Analysis of electrophysiological and functional parameters in TMEM184b mutant mice. A, Mutant mice hold on to an inverted screen
for significantly less time than their littermate controls. Two-tailed t test, p  0.0002. B–E, The compound motor action potential (CMAP) recorded from the plantar muscles of the foot (B), motor
nerve conduction velocity of the sciatic nerve (C), mixed orthodromic compound nerve action potential amplitude (D), and conduction velocity of the tail nerve (E) were unchanged between
littermate controls and TMEM184b mutants. For B–F, two-tailed t test, p  0.05. F, The weight of TMEM184b mutant mice is the same as littermate controls. N  8 mice/genotype/trial.
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processes can affect nerves and muscles simultaneously (Weihl et al.,
2015). The dystrophic presynaptic swellings we find in TMEM184b
mutants have also been reported in AxJ mice, which contain a spon-
taneous mutation in the deubiquitinating protease Usp14. AxJ mice
accumulate proteins in their terminals that were meant for degrada-
tion by the proteasome (Chen et al., 2009). Finally, mouse models of
infantile neuroaxonal dystrophy caused by mutations in the phos-
pholipase PLA2G6 deletion show ultrastructural terminals similar to
those of TMEM184b mutants (Malik et al., 2008; Sumi-Akamaru et
al., 2015). Thus, the membranous aggregates and swollen compart-
ments in TMEM184b mutant nerves and muscles could reflect ab-
normalities in degradation of cellular proteins similar to those
known to cause neurodegenerative disease.
We find that mutation of TMEM184b in mice results in severe
and progressive changes in synaptic and epidermal nerve termi-
nal architecture, and that TMEM184b loss affects sensory-motor
function (Figs. 4 – 6). It is very likely that the morphological
changes we observe contribute to the functional deficits; how-
ever, other explanations are possible. Given the widespread
expression of TMEM184b in the CNS and in particular the cere-
bellum (Allen Brain Atlas; M.R.C. Bhattacharya, unpublished ob-
servation), we cannot rule out the possibility that other cell types
participate in the generation of the behavioral phenotypes de-
scribed here (due to the ubiquitous nature of the gene-trap al-
lele). Interestingly, abnormalities are seen in skeletal muscle
(Fig. 5), even though virtually no mRNA for TMEM184b is
expressed in this tissue (Fig. 1), indicating that a noncell-
autonomous mechanism of action may be responsible for the
muscle phenotypes in this mouse.
Loss of TMEM184b has a protective phenotype within axons
following nerve injury in vivo (Fig. 3). It is thus one of a growing
list of proteins that play roles in axon degeneration following
injury or chemotherapy-induced toxicity, including Sarm1
(Osterloh et al., 2012; Gerdts et al., 2013, 2015), Phr1/highwire
(Xiong et al., 2012; Babetto et al., 2013), the dual leucine zipper
kinase/c-Jun N-terminal kinase pathway (Miller et al., 2009), the
mitochondrial permeability transition pore (Barrientos et al.,
2011), and Morn4 (Bhattacharya et al., 2012). Overexpression of
NMNAT1 (Mack et al., 2001; Araki et al., 2004) or maintenance
of NMNAT2 levels (Gilley and Coleman, 2010) also protects ax-
ons after injury. Links between Sarm1, DLK, and nicotinamide
adenine dinucleotide levels have recently emerged (Gerdts et al.,
2015; Yang et al., 2015), but the complete network of required
proteins is unknown.
While seemingly paradoxical, other examples exist of proteins
that alter synaptic architecture while also protecting axons from
degeneration, including Phr1/highwire, which functions as an
E3 ubiquitin ligase (Wan et al., 2000; Xiong et al., 2012; Babetto
et al., 2013). One possible explanation for our data is that
TMEM184b loss and the resulting disruption of membrane traf-
ficking could directly affect the activity of one or more of these
known pathways, leading to a protective phenotype in axons.
Another possibility is that disrupting synaptic structure by loss of
TMEM184b (or Phr1) could cause a low-level cellular stress,
triggering neurons to upregulate compensatory responses that
protect them from further insults. The relationship between
TMEM184b and Phr1, or other axon degeneration pathway com-
ponents, requires further study. Interestingly, Phr1 mutant mice
show similar axon swellings at NMJs (E. Babetto, personal com-
munication), suggesting commonalities in their roles in neurons.
The molecular function of the TMEM184b protein remains
to be determined. Though its membrane topology might sug-
gest that it is a G-protein-coupled receptor (GPCR), sequence
comparisons suggest that TMEM184b has a protein structure
most similar to bile acid transporters, rather than a similarity
to GPCRs. Its localization in recycling endosomes and at the
plasma membrane puts it in a position to have signaling roles
within neurons, and potentially between neurons and muscle.
Further work is necessary to identify the biological activity of
TMEM184b.
In summary, we have described the first roles for TMEM184b
in the mammalian nervous system in vivo. TMEM184b is critical
both for axon degeneration and for sensory and motor terminal
structure and function. Given that it is highly expressed in both
central and peripheral nervous system tissues, and given the im-
portance of proteostasis in neurodegenerative disease, future
work should investigate links between mutation in TMEM184b
and the development of neurodegenerative disease in humans.
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